Two Sigma Securities, LLC Cytom X Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.48 - $2.88 $25,984 - $50,564
-17,557 Reduced 61.9%
10,808 $16,000
Q4 2022

Feb 14, 2023
BUY
$1.19 - $1.91 $33,754 - $54,177
28,365 New
28,365 $45,000
Q2 2022

Aug 15, 2022
SELL
$1.53 - $2.89 $17,734 - $33,497
-11,591 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.67 - $4.68 $30,947 - $54,245
11,591 New
11,591 $31,000

Others Institutions Holding CTMX

# of Institutions
71
Shares Held
50.7M
Call Options Held
112K
Put Options Held
8.3K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $69.9M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email